Buy Supernus Pharmaceuticals Stock | SUPN Stock Price & Latest News | Public.com

Supernus Pharmaceuticals

$0.00 (0.00%)Today

    About SUPN

    Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    2

    Price Targets

    What analysts think this stock will be worth

    $23.63
    current
    $28.00
    average

    Events

    List of events that could affect this stock.

    05May

    Earnings data Q1 2020

    04Aug

    Earnings data Q2 2020

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.62
    0.41
    0.21
    0
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $0.43

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,24B
    Volume25,32k
    Price-to-Earnings Ratio10.92
    Dividend Rate
    Dividend Yield
    1 Year High$34.11
    1 Year Low$13.12
    Open$23.96
    High$24.00
    Low$23.36

    Buy any stock with any amount of money.

    Download the App
    Download the app